Delivery Order SPE2DB24D1104-SPE2DB24FYCA8

Award Date 8/26/24
Potential Completion Date 8/27/24
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical under a $2,190.10 delivery order. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support the...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $8,454.05 for the supply of Vyvanse 40mg capsules to the Defense Logistics Agency (DLA). The award is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, is for the supply of Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA). The $3,017.00 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $1,000.49 for the supply of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA). The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award is for the delivery of 100 capsules of the pharmaceutical product Vyvanse 40mg to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to the Corporate Office Division of Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract has a ceiling value of $5,909.10 and is a firm fixed-price delivery order. It was awarded on...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $5,990.61 Firm Fixed Price Delivery Order is for the supply of 4,565,393,326 units of Vyvanse 30 mg capsules, a prescription medication. The contract does not have a set-aside designation. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,564,320 units of the prescription drug Vyvanse (50 mg capsules) with a ceiling value of $2,619.59. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,414.32 firm fixed-price delivery order is for the supply of 100 units of the 30 mg capsule form of the drug Vyvanse. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA, which serves as the primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,684.66, is for the delivery of Vyvanse 40mg capsules to support federal healthcare programs. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999, which serves as the primary vehicle...
This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $11,047.92, is for the provision of 4,564,880,768 units of the prescription drug Vyvanse 40 mg capsules. The award has an ultimate completion date of June 12, 2024 and is a firm fixed price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB24FYCA8
    Delivery Order

This is a delivery order award to Amerisourcebergen Drug Corporation's Corporate Office Division valued at $4,126.36. The order is for the pharmaceutical product Vyvanse 30 mg capsules, which are being supplied to the Defense Logistics Agency (DLA), a defense agency. This award is not associated with any set-aside program. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by the DLA and other agencies to provide a wide range of prescription medications, medical supplies, and equipment to support military treatment facilities, veterans' hospitals, and other federal healthcare providers nationwide. Notable IDCs include a $999,999,999 contract with the DLA Troop Support Medical through 2025 and a $750,000 contract with the Department of Justice Federal Bureau of Investigation through 2024 for medical products and prescription drugs.

Generated 11/25/24, 9:15 AM